• Home
  • What is Stalpex?
  • Stalpex acquisition cost
  • Why choose Stalpex?
  • Support for payers
  • Support for patients
  • Prescribing information & ae reporting
  • Summary of product characteristics
  • Patient information leaflet
  • References

Intended for UK healthcare professionals

tree
staplex
view

What is Stalpex?

Stalpex contains 50/500 mcg salmeterol xinafoate/
fluticasone propionate dose inhalation powder.

Indications 3

Asthma
  • Stalpex is indicated for use in patients with severe asthma 12 years of age and older only

  • Regular treatment of patients with severe asthma, where use of a combination product (long-acting ß2 agonist and inhaled corticosteroid) is appropriate:

    • - patients not adequately controlled on a lower strength corticosteroid combination product, or
    • - patients already adequately controlled on an inhaled corticosteroid in a high strength and a long-acting ß2 agonist

COPD
  • Symptomatic treatment of patients with a FEV1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, with significant symptoms despite regular bronchodilator therapy

Dosing 3

Asthma
  • One inhalation twice daily. Once control of asthma is attained, treatment should be reviewed and consideration given to whether patients should be stepped down to a lower dose ICS/LABA combination or ICS alone

COPD
  • One inhalation twice daily

The Stalpex inhaler design
was recently updated, and both
shapes are available in the UK market.
The two designs are bioequivalent
and there is no difference in how
they are used by patients.3

Stalpex acquisition cost

Stalpex offers acquisition cost savings of over 50%
vs. the equivalent Seretide® pack. 1,2

One of the lowest costs of all dry powder inhaler salmeterol/fluticasone propionate 50/500 products.1,2

Seretide® Accuhaler ®
50/500 mcg strength

£32.741

Stalpex
50/500 mcg strength

£16.122

Sources: BNF February 20221; Data on file, Glenmark Pharmaceuticals Europe Ltd (STAL/2022/03/001)2

Prices correct at time of development but are subject to change without prior notice. E&OE.

Think Stalpex for all suitable salmeterol xinafoate/fluticasone propionate prescriptions

Prescribe Stalpex by brand to ensure:

  • glenamrk

    Your patients get the device
    prescribed

  • glenamrk

    You get the full acquisition cost savings for
    your practice

  • glenamrk

    Your health economy gets the full
    acquisition cost savings

Why choose Stalpex?

Stalpex 50/500 mcg offers an equivalent user
experience to Seretide® Accuhaler®3-6

  • The same active substance as Seretide® Accuhaler®3,5,6

  • Equivalent strength to 50/500 mcg Seretide® Accuhaler® dose5

  • A functionally equivalent DPI device4

  • Stalpex has been shown to deliver an equivalent dose to Seretide® Accuhaler® in equivalence studies5

…branching out in a
cost-conscious direction

imgage
graph
imgage

Support for payers

Glenmark can provide you with estimates of financial savings for your health economy. To find out how much your health authority could save, click on the link below to arrange an appointment.

Contact Us

Inspired thinking by Glenmark Respiratory

We’re proud of our work designed to make a difference in respiratory medicine. Visit our site to find out more and access free education resources.

Explore now

The Glenmark planned approach –
commitment to supply readiness

We are committed to ensuring Stalpex is available to order
from the moment a new customer comes on board:

Support for patients

When you prescribe Stalpex by brand, your patients have access to clear information and support to help ensure they take their medication correctly.

The Stalpex dedicated patient website contains information and support for patients prescribed Stalpex. Here they will find guidance
on how to use their inhaler, answers
to FAQs and links to trusted websites.
The website also highlights the
recent change in inhaler design,
(and how both shapes of inhalers are bioequivalent with no change to inhaler technique).4
Click here to view.

news

View the Stalpex demonstration video

You can use it to facilitate Stalpex device training with your patients.

The video can be accessed directly by patients prescribed Stalpex on the patient site.

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

By clicking this link, you are leaving the Stalpex website
and entering a third party website. Glenmark Pharmaceuticals has no control over
the content and management of third party websites and cannot be held responsible
or liable for this. Please check that the content of the website you are about
to visit is suitable for you, and that you are the intended audience.
It is recommended that you carefully read the legal notices, privacy
and cookie policies of third party websites before accessing them.

If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page'

References:

  1. 1.BNF. February 2022. (See NHS indicative price). Available at:
    https://bnf.nice.org.uk/medicinal-forms/fluticasone-with-salmeterol.html. Accessed March 2022.
  2. 2.Data on file, Glenmark Pharmaceuticals Europe Ltd (STAL/2022/03/001).
  3. 3.Stalpex Summary of Product Characteristics.
  4. 4.Data on file, Glenmark Pharmaceuticals Europe Limited (Device equivalence: STALP/2021/01/001).
  5. 5. MHRA April 2019 Public Assessment Report: Stalpex 50/500 Mcg UK/H/6498/03/DC. https://stalpex.co.uk/wp-content/uploads/2019/06/con952562.pdf. Accessed March 2022.
  6. 6.Seretide® Accuhaler® Summary of Product Characteristics.

Contact Glenmark


Your enquiry (please tick as applicable)
Arrange an appointment with a member of our sales team
Request Stalpex patient materials
General enquiry (use space below)

Your details will be processed in accordance with our Privacy Policy
available at https://glenmarkpharma.co.uk/privacy-policy/.

Seretide® and Accuhaler®are registered trademarks of the GlaxoSmithKline
group of companies.

Stalpex® is a registered trademark of Glenmark Pharmaceuticals Europe Limited.

PIP code: 4098661

© 2022 Glenmark Pharmaceuticals Europe Ltd. All rights reserved.
Date of preparation: April 2022 PP-UK-STAL-0016 V5

Adverse events should be reported.

Reporting forms and information can be found at
www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to medical_information@glenmarkpharma.com

or call 0800 458 0383.

  • Cookie Policy
  • Privacy Policy
  • Terms of use
  • About Glenmark
  • Contact us
We use necessary cookies to enhance your website experience, to ensure the site functions properly and to keep it secure. These need to always be on to ensure website functionality.
Additionally, we may use performance cookies to help us to continually improve our site by learning what is most useful to our site visitors. We may also use functional cookies to help manage your preferences and to remember your settings and targeting cookies to tailor advertising to your specific interests.
For more detailed information about the cookies we use, please visit our Cookies Policy
Cookie settings REJECT ACCEPT
Manage consent

Cookie policy

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually identify you, but it can give you a more personalised web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Blocking some cookies may limit your site experience.
Necessary
Always Enabled
Necessary cookies enable core functionality such as page navigation and access to secure areas. The website cannot function properly without these cookies.
Functional
Functional cookies allow us to remember choices you make during your visit to website - they are necessary to provide features and services to individual users.
Targeting
Targeting cookies track your online behaviour and share data with 3rd party services that help us improve the relevance of marketing campaigns you receive
Performance
Performance cookies track your online behaviour and share data with 3rd party services that help us improve the performance of the website.
Save & Accept